Literature DB >> 20800007

Nosocomial outbreak of Crimean-Congo haemorrhagic fever.

H R Naderi1, M R Sarvghad, A Bojdy, M R Hadizadeh, R Sadeghi, F Sheybani.   

Abstract

We report a nosocomial outbreak of Crimean-Congo haemorrhagic fever (CCHF) that affected six patients in June 2009 in Ghaem Hospital, Mashhad, Iran, apparently related to one index case. The last four cases were healthcare workers. Infection was spread by percutaneous exposure to two cases, and probably by direct contact with blood, clothes and sheets, to three others. The diagnosis in the two fatal cases was not confirmed virologically. The diagnosis in four cases who survived was confirmed by specific reverse transcription polymerase chain reaction. The patients were treated with ribavirin. In endemic areas, every patient presenting with a febrile haemorrhagic syndrome should be considered to have a viral haemorrhagic fever until proven otherwise. Patients who meet the criteria for probable CCHF should be admitted to hospital and treated with ribavirin. Appropriate isolation precautions should be immediately initiated.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20800007     DOI: 10.1017/S0950268810002001

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  16 in total

Review 1.  Recent advances in research on Crimean-Congo hemorrhagic fever.

Authors:  Anna Papa; Ali Mirazimi; Iftihar Köksal; Augustin Estrada-Pena; Heinz Feldmann
Journal:  J Clin Virol       Date:  2014-10-22       Impact factor: 3.168

Review 2.  Crimean-Congo hemorrhagic fever in Iran.

Authors:  Maryam Keshtkar-Jahromi; Mohammad M Sajadi; Hossein Ansari; Masoud Mardani; Kourosh Holakouie-Naieni
Journal:  Antiviral Res       Date:  2013-07-18       Impact factor: 5.970

3.  Fatal nosocomial spread of Crimean-Congo hemorrhagic fever with very short incubation period.

Authors:  HamidReza Naderi; Fereshte Sheybani; Amin Bojdi; Nasrin Khosravi; Irandokht Mostafavi
Journal:  Am J Trop Med Hyg       Date:  2012-12-26       Impact factor: 2.345

4.  Investigation of Crimean-Congo hemorrhagic fever virus transmission from patients to relatives: a prospective contact tracing study.

Authors:  Mustafa Gokhan Gozel; Mehmet Bakir; Atifet Yasemin Oztop; Aynur Engin; Ilyas Dokmetas; Nazif Elaldi
Journal:  Am J Trop Med Hyg       Date:  2013-10-28       Impact factor: 2.345

Review 5.  Crimean-Congo hemorrhagic fever and expansion from endemic regions.

Authors:  Jessica R Spengler; Éric Bergeron; Christina F Spiropoulou
Journal:  Curr Opin Virol       Date:  2019-01-16       Impact factor: 7.090

6.  An update on crimean congo hemorrhagic Fever.

Authors:  Suma B Appannanavar; Baijayantimala Mishra
Journal:  J Glob Infect Dis       Date:  2011-07

Review 7.  Rapid molecular detection methods for arboviruses of livestock of importance to northern Europe.

Authors:  Nicholas Johnson; Katja Voller; L Paul Phipps; Karen Mansfield; Anthony R Fooks
Journal:  J Biomed Biotechnol       Date:  2011-12-15

Review 8.  The global distribution of Crimean-Congo hemorrhagic fever.

Authors:  Jane P Messina; David M Pigott; Nick Golding; Kirsten A Duda; John S Brownstein; Daniel J Weiss; Harry Gibson; Timothy P Robinson; Marius Gilbert; G R William Wint; Patricia A Nuttall; Peter W Gething; Monica F Myers; Dylan B George; Simon I Hay
Journal:  Trans R Soc Trop Med Hyg       Date:  2015-07-04       Impact factor: 2.184

9.  Seroepidemiology of crimean congo hemorrhagic Fever in slaughterhouse workers in north eastern iran.

Authors:  S Chinikar; A Hezareh Moghadam; Sm J Parizadeh; M Moradi; N Bayat; M Zeinali; E Mostafavi
Journal:  Iran J Public Health       Date:  2012-11-01       Impact factor: 1.429

Review 10.  Effectiveness of Personal Protective Equipment for Healthcare Workers Caring for Patients with Filovirus Disease: A Rapid Review.

Authors:  Mona Hersi; Adrienne Stevens; Pauline Quach; Candyce Hamel; Kednapa Thavorn; Chantelle Garritty; Becky Skidmore; Constanza Vallenas; Susan L Norris; Matthias Egger; Sergey Eremin; Mauricio Ferri; Nahoko Shindo; David Moher
Journal:  PLoS One       Date:  2015-10-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.